A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 9443129)

Published in J Pediatr Gastroenterol Nutr on January 01, 1998

Authors

R B Colletti1, H S Winter, R J Sokol, F J Suchy, W J Klish, P R Durie

Author Affiliations

1: Department of Pediatrics, University of Vermont College of Medicine, Burlington, USA.

Articles by these authors

Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. dose-response effect. Pediatrics (2001) 4.29

Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet (2001) 2.73

MOMs (multiples of the median) and DADs (discriminant aneuploidy detection): improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs. Am J Obstet Gynecol (1995) 2.67

Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J Biol Chem (2001) 2.58

The expert witness: real issues and suggestions. Am J Obstet Gynecol (1995) 2.53

The increase in the cesarean birth rate. N Engl J Med (1980) 2.47

Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend (1987) 2.42

Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med (1991) 2.38

A revised conservative estimate of the incidence of FAS and its economic impact. Alcohol Clin Exp Res (1991) 1.95

Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res (1988) 1.92

Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis (1996) 1.91

Long-term results with the Kasai operation for biliary atresia. Arch Surg (1996) 1.90

Deficiency of immune interferon production by leukocytes of normal newborns. Cell Immunol (1980) 1.85

Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol (1992) 1.85

The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology (1997) 1.83

Clinical application of high-risk scoring on an obstetric service. Am J Obstet Gynecol (1977) 1.82

Altered platelet calcium metabolism as an early predictor of increased peripheral vascular resistance and preeclampsia in urban black women. N Engl J Med (1990) 1.80

Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr (1994) 1.79

Biliary atresia: current concepts and research directions. Summary of a symposium. Hepatology (1996) 1.78

Microvillus inclusion disease: an inherited defect of brush-border assembly and differentiation. N Engl J Med (1989) 1.77

Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed) (1981) 1.74

Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology (1982) 1.73

Screening for pregnancy risk-drinking. Alcohol Clin Exp Res (1994) 1.73

Prenatal alcohol exposure and infant information processing ability. Child Dev (1993) 1.71

Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr (1995) 1.70

Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest (1998) 1.68

Risk, antepartum care, and outcome: impact of a maternity and infant care project. Obstet Gynecol (1980) 1.68

New evidence for neurobehavioral effects of in utero cocaine exposure. J Pediatr (1996) 1.67

Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts. Hepatology (1998) 1.64

Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest (1988) 1.62

Navajo neurohepatopathy: a mitochondrial DNA depletion syndrome? Hepatology (2001) 1.57

Acute hepatic failure associated with the use of sodium valproate. N Engl J Med (1979) 1.55

Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr (1991) 1.55

Cloning and molecular characterization of the ontogeny of a rat ileal sodium-dependent bile acid transporter. J Clin Invest (1995) 1.52

High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med (1997) 1.51

Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut (1980) 1.50

Grade I Reye's syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med (1983) 1.49

Acute pancreatitis in childhood. J Pediatr (1988) 1.49

Relation of maternal age and pattern of pregnancy drinking to functionally significant cognitive deficit in infancy. Alcohol Clin Exp Res (1998) 1.48

Ringed esophagus: an association with esophagitis. Am J Gastroenterol (1992) 1.47

Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr (1999) 1.47

The relationship between nucleated red blood cell counts and early-onset neonatal seizures. Am J Obstet Gynecol (2000) 1.47

Outcome of syndromic paucity of interlobular bile ducts (Alagille syndrome) with onset of cholestasis in infancy. J Pediatr (1995) 1.45

Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption. Gut (1986) 1.44

Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol (1989) 1.44

Bone mineral density in 15- to 21-year-old eumenorrheic and amenorrheic subjects. Am J Dis Child (1992) 1.44

Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. Am J Clin Nutr (1996) 1.43

Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health (1996) 1.43

Large-volume paracentesis in the management of ascites in children. J Pediatr Gastroenterol Nutr (2001) 1.42

Effects of alcohol use, smoking, and illicit drug use on fetal growth in black infants. J Pediatr (1994) 1.42

Circulating antioxidant concentrations in children with inflammatory bowel disease. Am J Clin Nutr (1997) 1.41

The smaller than expected first-trimester fetus is at increased risk for chromosome anomalies. Am J Obstet Gynecol (1992) 1.41

Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics (2000) 1.41

Survey of maternal-fetal medicine subspecialists: professional activities, job setting, and satisfaction. Obstet Gynecol (1989) 1.40

Alagille syndrome: A nutritional niche for Notch. J Pediatr (1999) 1.40

Survival after aberrant right subclavian artery-esophageal fistula: case report and literature review. J Vasc Surg (1996) 1.38

Precise gaussian distribution functions of maternal serum alpha-fetoprotein and free beta-subunit of human chorionic gonadotropin for trisomy 21 screening: improved accuracy for patient counseling. Am J Obstet Gynecol (1997) 1.38

Early mental health intervention in combat situations: the USS Stark. Mil Med (1989) 1.38

The fiscal impact of the Medicaid abortion funding ban in Michigan. Obstet Gynecol (1993) 1.38

Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology (2001) 1.37

Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency. Pediatr Res (1986) 1.34

Disordered function of mononuclear phagocytes in malignant disease. J Clin Pathol (1983) 1.33

Transglutaminase antibodies in children with a genetic risk for celiac disease. J Pediatr (2000) 1.31

Impaired ability of patients with familial isolated vitamin E deficiency to incorporate alpha-tocopherol into lipoproteins secreted by the liver. J Clin Invest (1990) 1.31

Effects of long-term nutritional rehabilitation on body composition and clinical status in malnourished children and adolescents with cystic fibrosis. J Pediatr (1985) 1.30

Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr (1999) 1.30

Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy. N Engl J Med (1987) 1.28

Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr (1999) 1.28

Treatment of distal intestinal obstruction syndrome in cystic fibrosis with a balanced intestinal lavage solution. Lancet (1986) 1.28

Pathology of pancreatic and intestinal disorders in cystic fibrosis. J R Soc Med (1998) 1.28

Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27

Cellular hyperviscosity as a cause of neurological symptoms in leukaemia. Br Med J (1978) 1.27

Effects of fetal alcohol exposure on infant reaction time. Alcohol Clin Exp Res (1994) 1.27

Effects of prenatal exposure to alcohol, smoking, and illicit drugs on postpartum somatic growth. Alcohol Clin Exp Res (1994) 1.26

Evidence for a primary defect of pancreatic HCO3-secretion in cystic fibrosis. Pediatr Res (1982) 1.26

Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr (1998) 1.26

Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology (1996) 1.25

Pancreatic insufficiency, growth, and nutrition in infants identified by newborn screening as having cystic fibrosis. J Pediatr (1992) 1.25

Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med (1992) 1.25

Alcohol teratogenicity in the human: a detailed assessment of specificity, critical period, and threshold. Am J Obstet Gynecol (1987) 1.25

Fetal alcohol syndrome is now leading cause of mental retardation. Lancet (1986) 1.24

Maternal drinking behavior and decreased intrauterine growth. Alcohol Clin Exp Res (1982) 1.23

Teratogenic effects of alcohol on infant development. Alcohol Clin Exp Res (1993) 1.22

Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22

Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology (1996) 1.21

Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet (2001) 1.21

The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem (1989) 1.18

Autoimmune hemolysis: a critical review. Crit Rev Oncol Hematol (1985) 1.18

Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology (1984) 1.17

Epstein-Barr virus and post-transplant lymphoproliferative disease. Pediatr Transplant (2002) 1.17

Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord (2001) 1.16

Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr (1995) 1.16

Cholangiocyte biology and cystic fibrosis liver disease. Semin Liver Dis (2001) 1.16

An unusual presentation of Wegener's granulomatosis mimicking inflammatory bowel disease. Gastroenterology (1984) 1.16

Intrauterine exposure to low levels of lead: the status of the neonate. Arch Environ Health (1987) 1.15

Orthotopic liver transplantation for acute fulminant Wilson disease. J Pediatr (1985) 1.15

Ultrastructure of skin window cells in normal subjects. J Anat (1982) 1.15

Alcohol dehydrogenase-2*3 allele protects against alcohol-related birth defects among African Americans. J Pharmacol Exp Ther (1997) 1.14